Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers.
Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers.
It is a humanized monoclonal antibody that binds to hepatocyte growth factor, thus inhibiting the c-MET receptor signaling cascade.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).